Imunon chair granted 5,824 shares as salary

Imunon’s Executive Chairman received 5,824 shares as stock in lieu of cash salary, increasing his direct and IRA-linked holdings.

Rhea-AI Filing Summary

Imunon, Inc. (symbol: IMNN) is the issuer of record for a Form 4 filing submitted to the SEC. Tardugno Michael H reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. (IMNN) reported that Executive Chairman of the Board Michael H. Tardugno received a grant of 5,824 shares of Common Stock on September 11, 2026 at $1.47 per share, issued as stock in lieu of cash for base salary. Following this award, he holds 95,699 shares directly and 4,622 shares indirectly through an IRA. No transactions were reported under a Rule 10b5-1 trading plan.

Insider Trade Summary

Grant/Award: 5,824 shares

Grant/Award 2 txns

Insider Tardugno Michael H

Role Executive Chairman of Board

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	5,824	$1.47	$9K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 95,699 shares (Direct); Common Stock — 4,622 shares (Indirect, Held by IRA)

Footnotes (1)

1. F1. Stock granted in lieu of cash for base salary

Key Figures

Shares granted: 5,824 shares Grant price per share: $1.47 per share Direct holdings after transaction: 95,699 shares +1 more

4 metrics

Shares granted 5,824 shares Common Stock granted on September 11, 2026 in lieu of cash salary

Grant price per share $1.47 per share Valuation used for the September 11, 2026 stock grant

Direct holdings after transaction 95,699 shares Common Stock directly owned by Michael H. Tardugno after the grant

Indirect IRA holdings 4,622 shares Common Stock held indirectly through an IRA after the reported date

Key Terms

Stock granted in lieu of cash for base salary, Indirect ownership, IRA

3 terms

Stock granted in lieu of cash for base salary financial

"Footnote states: Stock granted in lieu of cash for base salary"

Indirect ownership financial

"Ownership type reported as indirect, nature of ownership Held by IRA"

IRA financial

"Nature of ownership described as Held by IRA"

An individual retirement account (IRA) is a savings account designed to help people put aside money for their retirement, often with tax advantages that encourage long-term savings. It matters to investors because it can grow over time, providing financial security later in life, and offers benefits that can reduce current taxes or allow investments to compound more effectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IMNN report for Michael H. Tardugno?

Imunon reported that Michael H. Tardugno received 5,824 shares of Common Stock on September 11, 2026 at $1.47 per share as stock granted in lieu of cash for base salary, classified as a grant or award acquisition.

How many IMNN shares does Michael H. Tardugno hold after this Form 4?

After the reported grant, Michael H. Tardugno holds 95,699 IMNN shares directly and 4,622 shares indirectly, with the indirect shares held through an IRA.

Was the IMNN insider grant to Michael H. Tardugno made under a Rule 10b5-1 plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the September 11, 2026 grant was made pursuant to a Rule 10b5-1 trading plan.

What was the price used for the IMNN stock granted to Michael H. Tardugno?

The 5,824 IMNN shares granted to Michael H. Tardugno on September 11, 2026 were valued at $1.47 per share, according to the Form 4 transaction detail.

How are some of Michael H. Tardugno’s IMNN shares held?

In addition to directly held shares, the Form 4 reports that 4,622 IMNN shares are held indirectly, with the nature of ownership described as “Held by IRA”.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 12:44 PM Accepted by SEC EDGAR 09/15/2026 - 12:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tardugno Michael H

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman of Board

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2026		A		5,824(1)	A	$1.47	95,699	D
Common Stock								4,622	I	Held by IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for base salary

	/s/ Jeffrey W. Church, Attorney in Fact for Michael H. Tardugno	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)